(Q43249112)

17 November 2017

Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use. (English)

1 reference

17 November 2017

1 reference

3

1 reference

17 November 2017

Carlos A C Mendes

1

1 reference

PubMed ID

19887593

17 November 2017

José A Cordeiro

series ordinal

2

1 reference

PubMed ID

19887593

17 November 2017

language of work or name

English

0 references

publication date

3 November 2009

1 reference

Annals of Pharmacotherapy

17 November 2017

1 reference

17 November 2017

43

1 reference

17 November 2017

12

1 reference

17 November 2017

1948-1955

1 reference

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

17 November 2017

1 reference

Polymyxin and Related Peptide Antibiotics

21 January 2018

1 reference

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

21 January 2018

1 reference

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

21 January 2018

1 reference

Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit--a homogeneous population?

21 January 2018

1 reference

21 January 2018

1 reference

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.

21 January 2018

1 reference

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

21 January 2018

1 reference

Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.

21 January 2018

1 reference

Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series

21 January 2018

1 reference

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

Four years' experience of intravenous colomycin in an adult cystic fibrosis unit

21 January 2018

1 reference

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

21 January 2018

1 reference

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

21 January 2018

1 reference

Nephrotoxicity of intravenous colistin: a prospective evaluation

21 January 2018

1 reference

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients

21 January 2018

1 reference

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

Neurotoxic and nephrotoxic effects of colistin in patients with renal disease

21 January 2018

1 reference

Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria

21 January 2018

1 reference

Risk factors for acute renal failure: inherent and modifiable risks.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M277

1 reference

17 November 2017

1 reference

PubMed ID

19887593